HTGM News and Press, HTG Molecular Diagnostics Inc. From 08/03/19

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

TUCSON, Ariz., July 25, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski, President and CEO, will present a corporate overview at the Canaccord Genuity 3...

TUCSON, Ariz., July 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2019 after the market close...

TUCSON, Ariz., July 15, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the introduction of two of its previously released assays, the HTG EdgeSeq TM DLBCL Cell of Origin...

TUCSON, Ariz., July 08, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the release of its HTG EdgeSeq TM Reveal data analytics software, version 1.2.0. HTG EdgeSeq Revea...

TUCSON, Ariz., July 01, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it presented its technology in an oral presentation at the annual WIN Symposium meeting for p...

TUCSON, Ariz., July 01, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it presented its technology in an oral presentation at the annual WIN Symposium meeting for p...

VBI Vaccines (NASDAQ: VBIV )  -54%  on announcing top-line results from PROTECT, a Phase 3 Study of Sci-B-Vac. More news on: VBI Vaccines Inc., Outlook Therapeutics, Inc., HTG Molecular Diagnostics, Inc., Stocks on the move, Read more ...

TUCSON, Ariz., May 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that on May 22, 2019 the Compensation Committee of its Board of Directors granted inducement stock optio...

HTG Molecular Diagnostics, Inc. (HTGM) Q1 2019 Earnings Conference Call May 9, 2019 4:30 P.M. ET Company Participants Monique Kosse - Investor Relations John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Jordan Abr...